Literature DB >> 18820078

Biofilm formation by Pneumocystis spp.

Melanie T Cushion1, Margaret S Collins, Michael J Linke.   

Abstract

Pneumocystis spp. can cause a lethal pneumonia in hosts with debilitated immune systems. The manner in which these fungal infections spread throughout the lung, the life cycles of the organisms, and their strategies used for survival within the mammalian host are largely unknown, due in part to the lack of a continuous cultivation method. Biofilm formation is one strategy used by microbes for protection against environmental assaults, for communication and differentiation, and as foci for dissemination. We posited that the attachment and growth of Pneumocystis within the lung alveoli is akin to biofilm formation. An in vitro system comprised of insert wells suspended in multiwell plates containing supplemented RPMI 1640 medium supported biofilm formation by P. carinii (from rat) and P. murina (from mouse). Dramatic morphological changes accompanied the transition to a biofilm. Cyst and trophic forms became highly refractile and produced branching formations that anastomosed into large macroscopic clusters that spread across the insert. Confocal microscopy revealed stacking of viable organisms enmeshed in concanavalin A-staining extracellular matrix. Biofilms matured over a 3-week time period and could be passaged. These passaged organisms were able to cause infection in immunosuppressed rodents. Biofilm formation was inhibited by farnesol, a quorum-sensing molecule in Candida spp., suggesting that a similar communication system may be operational in the Pneumocystis biofilms. Intense staining with a monoclonal antibody to the major surface glycoproteins and an increase in (1,3)-beta-D-glucan content suggest that these components contributed to the refractile properties. Identification of this biofilm process provides a tractable in vitro system that should fundamentally advance the study of Pneumocystis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820078      PMCID: PMC2643605          DOI: 10.1128/EC.00202-08

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  60 in total

1.  Pneumocystis carinii jiroveci pneumonia following infliximab infusion for Crohn disease: emphasis on prophylaxis.

Authors:  Kanan Sharma; Pallavi Rao; Padmini Krishnamurthy; Syed Ahsan Ali; Gregory Beck
Journal:  South Med J       Date:  2007-03       Impact factor: 0.954

2.  Pneumocystis pneumonia associated with infliximab in Japan.

Authors:  Masayoshi Harigai; Ryuji Koike; Nobuyuki Miyasaka
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

3.  Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.

Authors:  J M Hornby; E C Jensen; A D Lisec; J J Tasto; B Jahnke; R Shoemaker; P Dussault; K W Nickerson
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

4.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 5.  Pneumocystis and Trypanosoma cruzi: nomenclature and typifications.

Authors:  Scott A Redhead; Melanie T Cushion; Jacob K Frenkel; James R Stringer
Journal:  J Eukaryot Microbiol       Date:  2006 Jan-Feb       Impact factor: 3.346

6.  Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns.

Authors:  Susana García-Sánchez; Sylvie Aubert; Ismaïl Iraqui; Guilhem Janbon; Jean-Marc Ghigo; Christophe d'Enfert
Journal:  Eukaryot Cell       Date:  2004-04

7.  Antigenic differences associated with genetically distinct Pneumocystis carinii from rats.

Authors:  J Vasquez; A G Smulian; M J Linke; M T Cushion
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

8.  Properties of the major antigens of rat and human Pneumocystis carinii.

Authors:  M J Linke; M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

Review 9.  Current epidemiology of Pneumocystis pneumonia.

Authors:  Alison Morris; Jens D Lundgren; Henry Masur; Peter D Walzer; Debra L Hanson; Toni Frederick; Laurence Huang; Charles B Beard; Jonathan E Kaplan
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

10.  Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease.

Authors:  Soichi Itaba; Tsutomu Iwasa; Yojiro Sadamoto; Toshifumi Nasu; Tadashi Misawa; Koji Inoue; Hidehiko Shimokawa; Kazuhiko Nakamura; Ryoichi Takayanagi
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.487

View more
  26 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

Review 2.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 3.  Fungal morphogenesis.

Authors:  Xiaorong Lin; J Andrew Alspaugh; Haoping Liu; Steven Harris
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

4.  The Trophic Life Cycle Stage of the Opportunistic Fungal Pathogen Pneumocystis murina Hinders the Ability of Dendritic Cells To Stimulate CD4+ T Cell Responses.

Authors:  Heather M Evans; Andrew Simpson; Shu Shen; Arnold J Stromberg; Carol L Pickett; Beth A Garvy
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 5.  Fungal biofilms, drug resistance, and recurrent infection.

Authors:  Jigar V Desai; Aaron P Mitchell; David R Andes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

6.  Characterization of Pneumocystis murina Bgl2, an Endo-β-1,3-Glucanase and Glucanosyltransferase.

Authors:  Geetha Kutty; A Sally Davis; Kaitlynn Schuck; Mya Masterson; Honghui Wang; Yueqin Liu; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

7.  The life cycle stages of Pneumocystis murina have opposing effects on the immune response to this opportunistic, fungal pathogen.

Authors:  Heather M Evans; Grady L Bryant; Beth A Garvy
Journal:  Infect Immun       Date:  2016-08-29       Impact factor: 3.441

8.  Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection.

Authors:  Melanie T Cushion; Michael J Linke; Alan Ashbaugh; Tom Sesterhenn; Margaret S Collins; Keeley Lynch; Ronald Brubaker; Peter D Walzer
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

9.  Are members of the fungal genus pneumocystis (a) commensals; (b) opportunists; (c) pathogens; or (d) all of the above?

Authors:  Melanie T Cushion
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

10.  Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.

Authors:  Michael J Linke; Alan Ashbaugh; Margaret S Collins; Keeley Lynch; Melanie T Cushion
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.